128 related articles for article (PubMed ID: 30860015)
1. Case Report: Hyperreactive Malarial Splenomegaly Syndrome Diagnosed with Loop-Mediated Isothermal Amplification and Treated with Artemisinin-Based Combination Therapy.
Genderini FG; Haeseleer C; Cantinieaux B; Martin C
Am J Trop Med Hyg; 2019 May; 100(5):1187-1190. PubMed ID: 30860015
[TBL] [Abstract][Full Text] [Related]
2. Hyperreactive malaria in expatriates returning from sub-Saharan Africa.
Van den Ende J; van Gompel A; van den Enden E; Taelman H; Vanham G; Vervoort T
Trop Med Int Health; 2000 Sep; 5(9):607-11. PubMed ID: 11044274
[TBL] [Abstract][Full Text] [Related]
3. A case of hyper-reactive malarial splenomegaly. The role of rapid antigen-detecting and PCR-based tests.
Mothe B; Lopez-Contreras J; Torres OH; Muñoz C; Domingo P; Gurgui M
Infection; 2008 Mar; 36(2):167-9. PubMed ID: 17906843
[TBL] [Abstract][Full Text] [Related]
4. Hyperreactive malarial splenomegaly in expatriates.
Singh RK
Travel Med Infect Dis; 2007 Jan; 5(1):24-9. PubMed ID: 17161315
[TBL] [Abstract][Full Text] [Related]
5. Concomitant falciparum malaria and Hyperreactive Malarial Splenomegaly in an adolescent boy from eastern India: A tale of rare coincidences.
Pandey S; Halder P; Patra A; Mondal M; Ghosh S; Pal D; Halder SN; Modak DC; Guha SK
J Vector Borne Dis; 2020; 57(3):274-276. PubMed ID: 34472512
[TBL] [Abstract][Full Text] [Related]
6. Hyperreactive Malarial Splenomegaly Syndrome--Can the Diagnostic Criteria Be Improved?
McGregor A; Doherty T; Lowe P; Chiodini P; Newsholme W
Am J Trop Med Hyg; 2015 Sep; 93(3):573-6. PubMed ID: 26195458
[TBL] [Abstract][Full Text] [Related]
7. The hyper-reactive malarial splenomegaly: a systematic review of the literature.
Leoni S; Buonfrate D; Angheben A; Gobbi F; Bisoffi Z
Malar J; 2015 Apr; 14():185. PubMed ID: 25925423
[TBL] [Abstract][Full Text] [Related]
8. Development of hyperreactive malarious splenomegaly in an 8 year-old Caucasian boy, 18 months after residence in Africa.
Van den Ende J; Van Gompel A; Van den Enden E; Colebunders R
Ann Soc Belg Med Trop; 1994 Mar; 74(1):69-73. PubMed ID: 8024351
[TBL] [Abstract][Full Text] [Related]
9. Hyperreactive malarial splenomegaly is associated with low levels of antibodies against red blood cell and Plasmodium falciparum derived glycolipids in Yanomami Amerindians from Venezuela.
Vivas L; O'Dea KP; Noya O; Pabon R; Magris M; Botto C; Holder AA; Brown KN
Acta Trop; 2008 Mar; 105(3):207-14. PubMed ID: 18243148
[TBL] [Abstract][Full Text] [Related]
10. Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam.
Phuc BQ; Rasmussen C; Duong TT; Dong LT; Loi MA; Ménard D; Tarning J; Bustos D; Ringwald P; Galappaththy GL; Thieu NQ
Emerg Infect Dis; 2017 Apr; 23(4):715-717. PubMed ID: 28322709
[TBL] [Abstract][Full Text] [Related]
11. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
Tavul L; Hetzel MW; Teliki A; Walsh D; Kiniboro B; Rare L; Pulford J; Siba PM; Karl S; Makita L; Robinson L; Kattenberg JH; Laman M; Oswyn G; Mueller I
Malar J; 2018 Oct; 17(1):350. PubMed ID: 30290825
[TBL] [Abstract][Full Text] [Related]
13. Hyper-reactive malarial splenomegaly in the absence of raised IgM antibodies.
Haider M; Nizami S; Qureshi A; Raza A; Mahar FK; Beg MA
Trop Doct; 2013 Jan; 43(1):37-8. PubMed ID: 23443623
[TBL] [Abstract][Full Text] [Related]
14. [Hyper-reactive malarial splenomegaly].
Maazoun F; Deschamps O; Barros-Kogel E; Ngwem E; Fauchet N; Buffet P; Froissart A
Rev Med Interne; 2015 Nov; 36(11):753-9. PubMed ID: 26119345
[TBL] [Abstract][Full Text] [Related]
15. High Antimalarial Efficacy of Dihydroartemisinin-Piperaquine on the China-Myanmar Border: The Calm Before the Storm.
Fairhurst RM
Am J Trop Med Hyg; 2015 Sep; 93(3):436-437. PubMed ID: 26283745
[No Abstract] [Full Text] [Related]
16. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
17. Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.
Tran TH; Dolecek C; Pham PM; Nguyen TD; Nguyen TT; Le HT; Dong TH; Tran TT; Stepniewska K; White NJ; Farrar J
Lancet; 2004 Jan; 363(9402):18-22. PubMed ID: 14723988
[TBL] [Abstract][Full Text] [Related]
18. Serological similarities between hyperreactive malarial splenomegaly and splenic lymphoma in west Africa.
Wallace S; Bedu-Addo G; Rutherford TR; Bates I
Trans R Soc Trop Med Hyg; 1998; 92(4):463-7. PubMed ID: 9850411
[TBL] [Abstract][Full Text] [Related]
19. A 75-year-old missionary with fever, splenomegaly and pancytopenia.
Masfrancx D; De Munter P; Devos T
Acta Clin Belg; 2013; 68(3):225-8. PubMed ID: 24156227
[TBL] [Abstract][Full Text] [Related]
20. [Hyperreactive malarial splenomegaly in a European returning from Africa].
Granier H; Vatan R; Nicolas X; Richecoeur M; Martin J
Rev Med Interne; 1999 May; 20(5):431-3. PubMed ID: 10365415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
